CLINICAL_TRIALS
research
· 2026-02-20
Clinical Trial Update: Partial Tumor Irradiation and Immunotherapy for Unresectable Lung Cancer [NA]
Summary
A recruiting clinical trial is evaluating partial tumor irradiation in combination with immunotherapy for unresectable lung cancer, including lung adenocarcinom…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Karl Landsteiner University of Health Sciences | Conditions: Lung Adenocarcinoma, Bulky Tumors | NA | Status: RECRUITING